Regulations.gov document
Distribution of Certain Drug Products by Registered Blood Establishments and Comprehensive…
Notice · FDA-2005-N-0345 · posted Oct 9, 2008
Key facts
| Document ID | FDA-2005-N-0345-0002 |
|---|---|
| Title | Distribution of Certain Drug Products by Registered Blood Establishments and Comprehensive Hemophilia Diagnostic Treatment Centers That Qualify as Health Care Entities; Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; Policies, Requirements and Administrative Procedures |
| Document type | Notice |
| Subtype | Notice of Final Rule |
| Agency | FDA |
| Docket | FDA-2005-N-0345 |
| Posted | Oct 9, 2008 |
| Federal Register citation | 73 FR 59496 |
| FR document number | E8-24050 |
| CFR | 21 CFR 203,205 |
| Effective date | Oct 9, 2008 |
At a glance
- 1–9 Pages
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: